Maternal Health
Nurturing You Through Motherhood
Our maternal health services provide personalized, compassionate care to empower women during this sacred journey. From prenatal monitoring to postpartum recovery, we blend advanced technology with inclusive support to ensure you feel confident and cared for.
Subservices
Baseline Prenatal
Inclusive:
- CBC
- ABO/Rh Tpying
- FBS
- HbsAG
- VDRL/RPR
- Urinalysis
- HIV
Comprehensive First Trimester
Inclusive:
- CBC
- ABO/Rh Tpying
- 75gOGTT
- HbsAG
- VDRL/RPR
- Urinalysis
- HIV
- Rubella IgG
Advance First Trimester
Inclusive:
- CBC
- ABO/Rh Tpying
- 75gOGTT
- HbsAG
- VDRL/RPR
- Urinalysis
- HIV
- Rubella IgG
- TVS
Basic Non-Invasive Prenatal Testing
A blood test performed as early as 9-10 weeks of pregnancy that analyzes cell-free fetal DNA circulating in maternal blood to screen for chromosomal abnormalities.
Screens for:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome abnormalities (X, Y)
- Fetal sex determination
Advantages: Higher accuracy than traditional screening (>99% detection rate), lower false-positive rates, no risk to pregnancy.
Comprehensive Non-Invasive Prenatal Testing
NIPT Extended
An expanded version of standard NIPT that screens for additional chromosomal conditions beyond the common trisomies.
Additional screening includes:
- Microdeletions/microduplications (22q11.2 deletion syndrome, Prader-Willi/Angelman syndromes, etc.)
- Additional autosomal trisomies (Trisomy 16, 22)
- Triploidy
- Some single-gene disorders (depending on laboratory)
Considerations: While more comprehensive, extended panels may have higher false-positive rates for rare conditions and require careful genetic counseling to interpret results appropriately.
Both tests are screening tools – abnormal results typically require diagnostic confirmation through amniocentesis or CVS.
DNA Grow Baby
A genetic test designed for women planning pregnancy, currently pregnant, or trying to conceive. Analyzes 42 genetic variants (SNPs) across 11 biological pathways that influence maternal and fetal health outcomes.
Purpose: Provides insights into factors affecting maternal health risks and fetal development to help optimize pregnancy outcomes from preconception through birth.
Key Areas Assessed
- Pregnancy complications risk
- Fetal development factors
- Maternal nutritional needs
- Birth outcome optimization
Target Population: Newly pregnant women, women planning to conceive, or those with previous pregnancy complications.
Clinical Value: Enables personalized diet, supplement, and lifestyle interventions based on genetic variations to optimize health outcomes for both mother and baby.
The test is offered by DNA Life (a collaboration between Nordic Laboratories and DNAlysis Biotechnology) and is designed to complement other functional health tests.
First Trimester Screening
A combination blood test and ultrasound performed at 10-14 weeks of pregnancy to assess the risk of chromosomal abnormalities like Down syndrome.
Includes:
- Blood tests: PAPP-A and free β-hCG levels
- Ultrasound: Nuchal translucency measurement and basic fetal assessment
Purpose: Calculates personalized risk ratios for Trisomy 21, 18, and 13. This is screening only – abnormal results may lead to diagnostic testing options like CVS or amniocentesis.
Timing: Must be done between 10-14 weeks gestation for accuracy.
Prenatal Support IV
Inclusive:
- Folate
- B vitamins
- Vitamin C
- Magnesium
- Safe mineral blend
Morning Sickness Relief
Inclusive:
- B6
- Magnesium
- Ondansetron (anti-nausea)
- Electrolytes
Start Your Journey with Confidence
Eluvo has supported mothers with personalized care, achieving low complication rates and high patient satisfaction. Your maternal health matters, and we’re here to walk alongside you. Let Eluvo empower you to embrace motherhood with strength and joy.
Empower Your Health Journey
Tips and Insights from Eluvo
Understanding IVF: Your Path to Parenthood with Eluvo
The Power of Personalized Women’s Health: Why One Size Doesn’t Fit All
